表1.
CCND2表达与PTC患者临床病理特征的关系
Tab.1 Relationship between CCND2 expression and clinicopathological characteristics of PTC patients [n (%)]
| Clinicopathological parameters | n | CCND2 positive | χ2 | P | |
|---|---|---|---|---|---|
| Gender | Male | 32 | 22 (68.75) | 0.4622 | 0.4966 |
| Female | 84 | 63 (75.00) | |||
| Age (year) | <55 | 79 | 55 (69.62) | 1.9627 | 0.1612 |
| ≥55 | 37 | 30 (81.08) | |||
| Tumor size (cm) | <1 | 76 | 50 (65.79) | 4.6911 | 0.0303 |
| ≥1 | 40 | 35 (75.00) | |||
| Multifocal | Yes | 40 | 26 (65.00) | 2.1353 | 0.1439 |
| No | 76 | 59 (77.63) | |||
| Extraglandular invasion | Yes | 13 | 11 (84.62) | 0.9614 | 0.3268 |
| No | 103 | 74 (71.84) | |||
| Lymphatic metastasis | Yes | 43 | 38 (88.37) | 7.9520 | 0.0048 |
| No | 73 | 47 (64.38) | |||
| TNM staging | I-II | 100 | 70 (70.00) | 12.1309 | 0.0005 |
| III-IV | 16 | 15 (93.75) |